|
SOBERANA CENTRO |
|
SOBERANA PEDIATRIA CLINICA 1 |
|
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
|
CIGB-Mambisa/Abdala in convalescents |
|
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
|
Itolizumab-Plasmapheresis in patients with COVID-19 |
|
Anti SARS-CoV-2 gammaglobulin |
|
Policosanol + aspirin in post-stroke cognitive impairment |
|
Policosanol in patients with pre-hypertension or with grade I hypertension |
|
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders |
|
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) |
|
SOBERANA PEDIATRIA |
|
D004 (Palmex) vs Saw palmetto, Finasteride and Tamsulosin in patients with BPH |
|
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms |
|
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
|
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
|
Nimotuzumab in COVID-19 |
|
CIMAvax-EGF in different maintenance schemes |
|
Doxycycline for prostate cancer |
|
SOBERANA PLUS |
